Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protection
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
A NA clinical study on Coronary Heart Disease and Obesity, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 10 data snapshots since 2010. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Aug 2020 — Nov 2020 [monthly]
Completed NA
-
Jun 2018 — Aug 2020 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- Pennington Biomedical Research Center
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .